Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Beneo(TM) Synergy 1 Protects Seniors’ Health
Results of the new study demonstrate that Beneo(TM) Synergy 1, combined with probiotics like the active cultures in yogurt, help reverse such digestive ‘aging,’ to the improvement of intestinal function and well being.
- Beneo(TM) Synergy 1 Protects Seniors’ Health
Results of the new study demonstrate that Beneo(TM) Synergy 1, combined with probiotics like the active cultures in yogurt, help reverse such digestive ‘aging,’ to the improvement of intestinal function and well being.
- Beneo(TM) Synergy 1 Protects Seniors’ Health
Results of the new study demonstrate that Beneo(TM) Synergy 1, combined with probiotics like the active cultures in yogurt, help reverse such digestive ‘aging,’ to the improvement of intestinal function and well being.
- Beneo(TM) Synergy 1 Protects Seniors’ Health
Results of the new study demonstrate that Beneo(TM) Synergy 1, combined with probiotics like the active cultures in yogurt, help reverse such digestive ‘aging,’ to the improvement of intestinal function and well being.
- Beneo(TM) Synergy 1 Protects Seniors’ Health
Results of the new study demonstrate that Beneo(TM) Synergy 1, combined with probiotics like the active cultures in yogurt, help reverse such digestive ‘aging,’ to the improvement of intestinal function and well being.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Study Indicates That GliSODin® May Provide Significant Protection Against UV Radiation-induced Skin Changes
In double-blind, placebo controlled study, UV skin burn (actinic erythema) was induced on the inner-forearms of healthy subjects before supplementation with GliSODin or placebo, and each week for four weeks during supplementation; color of the skin was measured by chromometry, and changes in skin due to inflammation were assessed by videocapillaroscopy.
- Study Indicates That GliSODin® May Provide Significant Protection Against UV Radiation-induced Skin Changes
In double-blind, placebo controlled study, UV skin burn (actinic erythema) was induced on the inner-forearms of healthy subjects before supplementation with GliSODin or placebo, and each week for four weeks during supplementation; color of the skin was measured by chromometry, and changes in skin due to inflammation were assessed by videocapillaroscopy.
- Study Indicates That GliSODin® May Provide Significant Protection Against UV Radiation-induced Skin Changes
In double-blind, placebo controlled study, UV skin burn (actinic erythema) was induced on the inner-forearms of healthy subjects before supplementation with GliSODin or placebo, and each week for four weeks during supplementation; color of the skin was measured by chromometry, and changes in skin due to inflammation were assessed by videocapillaroscopy.
- Study Indicates That GliSODin® May Provide Significant Protection Against UV Radiation-induced Skin Changes
In double-blind, placebo controlled study, UV skin burn (actinic erythema) was induced on the inner-forearms of healthy subjects before supplementation with GliSODin or placebo, and each week for four weeks during supplementation; color of the skin was measured by chromometry, and changes in skin due to inflammation were assessed by videocapillaroscopy.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Irritable Bowel Syndrome (IBS) Study - Recruiting Completed
Company announces completion of recruiting for their Irritable Bowel Syndrome (IBS) Clinical Trial utilizing ImmunoLin.
- Irritable Bowel Syndrome (IBS) Study - Recruiting Completed
Company announces completion of recruiting for their Irritable Bowel Syndrome (IBS) Clinical Trial utilizing ImmunoLin.
- Irritable Bowel Syndrome (IBS) Study - Recruiting Completed
Company announces completion of recruiting for their Irritable Bowel Syndrome (IBS) Clinical Trial utilizing ImmunoLin.
- Irritable Bowel Syndrome (IBS) Study - Recruiting Completed
Company announces completion of recruiting for their Irritable Bowel Syndrome (IBS) Clinical Trial utilizing ImmunoLin.
- Natural Extract for Treating MRSA Presented
Research on allicin presented at American Society for Microbiology meeting in Atlanta.
- Natural Extract for Treating MRSA Presented
Research on allicin presented at American Society for Microbiology meeting in Atlanta.
- Omega-3 offers hope for new anti-breast cancer drugs
Research published today in the journal Breast Cancer Research indicates that Compounds of Omega-3 fatty acids and propofol reduce the ability of breast cancer cells to develop into malignant tumours, inhibit cancer cell migration by 50% and significantly reduce their metastatic activity.
- Omega-3 offers hope for new anti-breast cancer drugs
Research published today in the journal Breast Cancer Research indicates that Compounds of Omega-3 fatty acids and propofol reduce the ability of breast cancer cells to develop into malignant tumours, inhibit cancer cell migration by 50% and significantly reduce their metastatic activity.
- Omega-3 offers hope for new anti-breast cancer drugs
Research published today in the journal Breast Cancer Research indicates that Compounds of Omega-3 fatty acids and propofol reduce the ability of breast cancer cells to develop into malignant tumours, inhibit cancer cell migration by 50% and significantly reduce their metastatic activity.
- Omega-3 offers hope for new anti-breast cancer drugs
Research published today in the journal Breast Cancer Research indicates that Compounds of Omega-3 fatty acids and propofol reduce the ability of breast cancer cells to develop into malignant tumours, inhibit cancer cell migration by 50% and significantly reduce their metastatic activity.
- Omega-3 offers hope for new anti-breast cancer drugs
Research published today in the journal Breast Cancer Research indicates that Compounds of Omega-3 fatty acids and propofol reduce the ability of breast cancer cells to develop into malignant tumours, inhibit cancer cell migration by 50% and significantly reduce their metastatic activity.
- New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications
Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA.
- New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications
Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA.
- New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications
Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA.
- New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications
Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA.
- New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications
Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA.
- Advitech Announces Completion of 2nd Study on XP-828L For Psoriasis
multi-centre, randomized double-blind, placebo-controlled study was conducted over a 112-day period; final results to be released July 5, 2005.
- Advitech Announces Completion of 2nd Study on XP-828L For Psoriasis
multi-centre, randomized double-blind, placebo-controlled study was conducted over a 112-day period; final results to be released July 5, 2005.
- Advitech Announces Completion of 2nd Study on XP-828L For Psoriasis
multi-centre, randomized double-blind, placebo-controlled study was conducted over a 112-day period; final results to be released July 5, 2005.
- Advitech Announces Completion of 2nd Study on XP-828L For Psoriasis
multi-centre, randomized double-blind, placebo-controlled study was conducted over a 112-day period; final results to be released July 5, 2005.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- New Study Published In Leading Journal Reinforces Safety Of Chromax(R) Chromium Picolinate
Results of a new study reaffirming the safety of Chromax® chromium picolinate will be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis.
- The Quigley Corporation Announces Results of Animal Model Inflammation Studies of Its QR440 Botanical, Anti-Inflammatory Compound
Company has obtained results from a series of In-Vivo (animal model) inflammation studies, finds Delayed-Type- Hypersensitivity T cell response reduced in mice, and granulyte movement to inflammation site also reduced.
- The Quigley Corporation Announces Results of Animal Model Inflammation Studies of Its QR440 Botanical, Anti-Inflammatory Compound
Company has obtained results from a series of In-Vivo (animal model) inflammation studies, finds Delayed-Type- Hypersensitivity T cell response reduced in mice, and granulyte movement to inflammation site also reduced.
- Ladislav Pataki to Head Research and Development at Ameritech International Corp.
Ladislav Pataki, PhD, CSc, ISASc has been appointed Director of Research and Development at Ameritech International Corp. Dr. Pataki developed both the PowerLean and NutrLife health and wellness lines of products recently purchased by Ameritech.
- Ladislav Pataki to Head Research and Development at Ameritech International Corp.
Ladislav Pataki, PhD, CSc, ISASc has been appointed Director of Research and Development at Ameritech International Corp. Dr. Pataki developed both the PowerLean and NutrLife health and wellness lines of products recently purchased by Ameritech.
- Ladislav Pataki to Head Research and Development at Ameritech International Corp.
Ladislav Pataki, PhD, CSc, ISASc has been appointed Director of Research and Development at Ameritech International Corp. Dr. Pataki developed both the PowerLean and NutrLife health and wellness lines of products recently purchased by Ameritech.
- Ladislav Pataki to Head Research and Development at Ameritech International Corp.
Ladislav Pataki, PhD, CSc, ISASc has been appointed Director of Research and Development at Ameritech International Corp. Dr. Pataki developed both the PowerLean and NutrLife health and wellness lines of products recently purchased by Ameritech.
- Ladislav Pataki to Head Research and Development at Ameritech International Corp.
Ladislav Pataki, PhD, CSc, ISASc has been appointed Director of Research and Development at Ameritech International Corp. Dr. Pataki developed both the PowerLean and NutrLife health and wellness lines of products recently purchased by Ameritech.
- Ladislav Pataki to Head Research and Development at Ameritech International Corp.
Ladislav Pataki, PhD, CSc, ISASc has been appointed Director of Research and Development at Ameritech International Corp. Dr. Pataki developed both the PowerLean and NutrLife health and wellness lines of products recently purchased by Ameritech.
- Ladislav Pataki to Head Research and Development at Ameritech International Corp.
Ladislav Pataki, PhD, CSc, ISASc has been appointed Director of Research and Development at Ameritech International Corp. Dr. Pataki developed both the PowerLean and NutrLife health and wellness lines of products recently purchased by Ameritech.
- Ladislav Pataki to Head Research and Development at Ameritech International Corp.
Ladislav Pataki, PhD, CSc, ISASc has been appointed Director of Research and Development at Ameritech International Corp. Dr. Pataki developed both the PowerLean and NutrLife health and wellness lines of products recently purchased by Ameritech.
- Advitech Announces Positive Results of XP-828L Study In Psoriasis
Company reports positive results from its recently completed randomized, multi-center, double-blind, placebo-controlled clinical trial of XP-828L, confirming efficacy and safety.
- Advitech Announces Positive Results of XP-828L Study In Psoriasis
Company reports positive results from its recently completed randomized, multi-center, double-blind, placebo-controlled clinical trial of XP-828L, confirming efficacy and safety.
- Advitech Announces Positive Results of XP-828L Study In Psoriasis
Company reports positive results from its recently completed randomized, multi-center, double-blind, placebo-controlled clinical trial of XP-828L, confirming efficacy and safety.
- Advitech Announces Positive Results of XP-828L Study In Psoriasis
Company reports positive results from its recently completed randomized, multi-center, double-blind, placebo-controlled clinical trial of XP-828L, confirming efficacy and safety.
- Saw Palmetto and Nettle Root Combination Effective for Prostate and Urinary Problems in Elderly Men
Randomized, double-blind, placebo-controlled trial was conducted by researchers at the Institute of Urology in Moscow on 257 men, and examined the effectiveness of an herbal blend combining saw palmetto and nettle root extracts in treating urinary tract difficulties in older men.
- Saw Palmetto and Nettle Root Combination Effective for Prostate and Urinary Problems in Elderly Men
Randomized, double-blind, placebo-controlled trial was conducted by researchers at the Institute of Urology in Moscow on 257 men, and examined the effectiveness of an herbal blend combining saw palmetto and nettle root extracts in treating urinary tract difficulties in older men.
- Saw Palmetto and Nettle Root Combination Effective for Prostate and Urinary Problems in Elderly Men
Randomized, double-blind, placebo-controlled trial was conducted by researchers at the Institute of Urology in Moscow on 257 men, and examined the effectiveness of an herbal blend combining saw palmetto and nettle root extracts in treating urinary tract difficulties in older men.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- New Company for “Change-The-World” Entrepreneurs™ Launches
- GMP Labs Expands Liquid Nutraceutical Capabilities
- What Parents Should Know About Kids and Supplements
- What Parents Should Know About Kids and Supplements
- Oats Beat Back Cholesterol
- Oats Beat Back Cholesterol
- Seniors: Pump Up for Strong Bones and Heart
- Seniors: Pump Up for Strong Bones and Heart
- Vitamin K2 as MK-7 (MenaQ7®) supplementation - essential for better bone health after organ transplantation
- Vitamin K2 as MK-7 (MenaQ7®) supplementation - essential for better bone health after organ transplantation
|
Compounds found in raisins fight bacteria in the mouth that cause cavities and gum disease, according to research presented today at the 105th General Meeting of the American Society for Microbiology.
"Our laboratory analyses showed that phytochemicals in this popular snack food suppress the growth of several species of oral bacteria associated with caries and gum disease," said Christine D. Wu, Professor and Associate Dean for Research at the University of Illinois at Chicago College of Dentistry and lead author of the study.
Routine chemical analyses identified five compounds in Thompson seedless raisins: oleanolic acid, oleanolic aldehyde, betulin, betulinic acid, and 5-(hydroxymethyl)-2-furfural. All of these are known phytochemicals -- antioxidants found in plants.
Oleanolic acid inhibited the growth of two species of oral bacteria: Streptococcus mutans, which causes cavities, and Porphyromonas gingivalis, which causes periodontal disease.
The compound was effective against the bacteria at concentrations ranging from about 4 to 1,000 µg/ml. At a concentration of 31 µg/ml, oleanolic acid also blocked S. mutans adherence to surfaces. Adherence is crucial for the bacteria to form dental plaque, the sticky biofilm consisting of oral bacteria that accumulates on teeth. After a sugary meal, these bacteria release acids that erode the tooth enamel.
Wu said that the data counter a longstanding public perception that raisins promote cavities.
"Raisins are perceived as sweet and sticky, and any food that contains sugar and is sticky is assumed to cause cavities," Wu said. "But our study suggests the contrary. Phytochemicals in raisins may benefit oral health by fighting bacteria that cause cavities and gum disease."
In an earlier unpublished study, Wu's collaborator Dr. Shahrbanoo Fadavi (Pediatric Dentistry, UIC College of Dentistry) found that adding raisins to bran cereal did not increase the acidity of dental plaque. However, the commercial raisin-bran cereal with added sugar was most acidogenic compared with raisins or bran cereal alone.
"Foods that are sticky do not necessarily cause tooth decay; it is mainly the added sugar (sucrose) that contributes to the problem" Wu said.
The present study was funded by the California Raisin Marketing Board.
Besides collaborator Dr. A. Douglas Kinghorn, Adjunct Professor at the UIC College of Pharmacy, other scientists involved in the study were Dr. Jose F. Rivero-Cruz and Dr. Min Zhu (both, UIC College of Dentistry) and Dr. Baoning Su (UIC College of Pharmacy).
### |